Growth Metrics

Envoy Medical (COCH) Capital Expenditures (2022 - 2025)

Envoy Medical's Capital Expenditures history spans 4 years, with the latest figure at $172000.0 for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 132.21% to $172000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $179000.0, a 81.73% decrease, with the full-year FY2025 number at $179000.0, down 81.73% from a year prior.
  • Capital Expenditures hit $172000.0 in Q4 2025 for Envoy Medical, up from $1000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for COCH hit a ceiling of $1.2 million in Q3 2024 and a floor of -$534000.0 in Q4 2024.
  • Historically, Capital Expenditures has averaged $112750.0 across 4 years, with a median of $50000.0 in 2022.
  • The widest YoY moves for Capital Expenditures: up 2154.55% in 2024, down 2642.86% in 2024.
  • Tracing COCH's Capital Expenditures over 4 years: stood at $41000.0 in 2022, then crashed by 48.78% to $21000.0 in 2023, then plummeted by 2642.86% to -$534000.0 in 2024, then surged by 132.21% to $172000.0 in 2025.
  • Business Quant data shows Capital Expenditures for COCH at $172000.0 in Q4 2025, $1000.0 in Q2 2025, and $6000.0 in Q1 2025.